Breast cancer and pregnancy; Overview of international bibliography
K. Kalogerakos, C. Sofoudis, P. Tzonis, P. Koutsouradis, G. Katsoulis; pp 308-313 (Abstract, PDF)
Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a
retrospective study
M. Bulent Akinci, E. Algin, A. Inal, H. Odabas, V. Berk, U. Coskun, U. Uyeturk, A. Isikdogan, S. Aksoy, B.
Civelek, A. Sevinc, S. Buyukberber; pp 314-320 (Abstract, PDF)
Change of influence of prognostic markers on metastasis free interval during and after adjuvant tamoxifen
therapy in breast cancer patients
Z. Abu Rabi, N. Todorovic-Rakovic, M. Markicevic, L. Stamatovic, T. Vujasinovic, D. Nikolic-Vukosavljevic; pp 321-327 (Abstract, PDF)
Breast cancer in octogenarian women: clinical characteristics and outcome
T. Y. Kuzan, E. Koca, O. Dizdar, C. Arslan, T. Eren, S. Yalcin, N. Kucukoztas, S.Aksoy, S. Rahatli, D. S. Dede,
O. Altundag, N. Zengin, O. Ozyilkan, K. Altundag; 328-334 (Abstract, PDF)
The prognostic impact of obesity on molecular subtypes of breast cancer
in premenopausal women
F. P. Turkoz, M. Solak, I. Petekkaya, O. Keskin, N. Kertmen, F. Sarici, Z. Arik, T. Babacan, Y. Ozisik, K.
Altundag; pp 335-341 (Abstract, PDF)
Estimation of maspin’s subcellular localization in invasive ductal breast cancer via light microscopy
and computerized image analysis: a comparative study
M. Panou, N. Kavantzas MD, T. Sergentanis, S. Sakellariou, G. Agrogiannis, P. Chatzipantelis, E. Anastasopoulou,
V. Soranoglou, F. Zagouri, P. Korkolopoulou, E. Patsouris, I. Bramis MD, G. C. Zografos; pp 342-351 (Abstract, PDF)
The role of ThinPrep cytology in the investigation of ki-67 index, p53 and HER-2 detection in
fine-needle aspirates of breast tumors
P. Konofaos, K. Kontzoglou, P. Parakeva, C. Kittas, N. Margari, E. Giaxnaki, M. Pouliakis, G. Kouraklis, P.
Karakitsos; pp 352-358 (Abstract, PDF)
Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23
expression in patients with invasive breast cancer
E. Cubukcu, O. Kanat, O. Fatih Olmez, S. Kabul, M. Canhoroz, N. Avci, A. Deligonul, M. Hartavi, S. Cubukcu,
F. Olmez, E. Kurt, T. Evrensel, S. Gokgoz, O. Manavoglu; pp 359-365 (Abstract, PDF)
Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with
administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel
chemotherapy
D. S. Dede, B. Gumuskaya, G. Guler, D. Onat, K. Altundag, Y. Ozisik; pp 366-371 (Abstract, PDF)
Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer
B. Cakar, U. Varol, B. Junushova, U. Muslu, P. Gursoy Oner, Z. Gokhan Surmeli, Y. Cirak, B. Karaca, C.
Sezgin, B. Karabulut, R. Uslu ; pp 372-376 (Abstract, PDF)
A modified DCF regimen as primary treatment for patients with metastatic gastric cancer
D. Koca, E. Dogan, H. Yardim, O. Duzen, S. Karaca; pp 377-384 (Abstract, PDF)
Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal
cancer
D. Tural, M. Ozturk, F. Selcukbiricik, O. Yildiz, O. Elicin, H. Turna, S. Guney, M. Ozguroglu; pp 385-390 (Abstract, PDF)
D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer
M. Inanc, O. Er, H. Karaca, V. Berk, M. Ozkan, M. Dikilitas, F. Elmali; pp 391-397 (Abstract, PDF)
Prognostic significance of vascular endothelial growth factor expression in esophageal
carcinoma: a meta-analysis
Jun Peng, Na Shao, Hongling Peng, Long-Qi Chen; pp 398-406 (Abstract, PDF)
A weekly hypofractionated radiotherapeutic schedule for bladder carcinoma in elderly patients: local
response, acute and late toxicity, dosimetric parameters and pain relief
A. Zygogianni, V. Kouloulias, C. Armpilia, C. Antypas, I. Kantzou, M. Balafouta, G. Kyrgias, G. Sarris, N.
Kelekis, J. Kouvaris; pp 407-412 (Abstract, PDF)
The association of hematologic parameters on the prognosis of patients with metastatic renal cell
carcinoma
A. Dirican, Y. Kucukzeybek, I. Somali, C. Erten, L. Demir, A. Can, K. Bahriye Payzin, I. Vedat Bayoglu, M.
Akyol, M. Koseoglu, A. Alacacioglu, M. Oktay Tarhan; pp 413-419 (Abstract, PDF)
Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification
Lujia Wang, Chenchen Feng, Guanxiong Ding, Zhongwen Zhou, Haowen Jiang, Zhong Wu; pp 420-424 (Abstract, PDF)
Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk
medulloblastoma: A 5-year follow-up study
H.A. Wahba, M. Abu-Hegazy, Y. Wasel, E.I. Ismail, A. S. Zida; pp 425-429 (Abstract, PDF)
Prognostic value of peritumoral edema and angiogenesis in intracranial meningioma surgery
M. Markovic, V. Antunovic, S. Milenkovic, N. Zivkovic; pp 430-436 (Abstract, PDF)
miR-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia
cells
B. Firatligil, C. Biray Avci, Y. Baran; pp 437-441 (Abstract, PDF)
The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons
in real time PCR of IgH gene rearrangements and correlation with flow cytometry
I. O. Kara, B. B. Duman, C. U. Afsar; pp 442-447 (Abstract, PDF)
Multiple myeloma in association with second malignancy
J.Grudeva-Popova, I.Nenova, М.Spasova, М.Yaneva, Е.Beleva, N.Аnanoshtev; pp 448-452 (Abstract, PDF)
Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer
patients?
I. Alsan Cetin, Z. Akgun, Beste M. Atasoy, P. Fulden Yumuk, U. Abacioglu; pp 453-458 (Abstract, PDF)
Negative prognostic factors for head and neck cancer in the young
K. Kourelis, T. Tsue, D. Girod, O. Tawfik, K. Sykes, Y. Shnayder; pp 459-464 (Abstract, PDF)
Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial
carcinoma
Ting Guo, Bin Li, Chao Gu; pp 465-470 (Abstract, PDF)
Correlation of nuclear morphometry of primary melanoma of the skin with clinicopathological parameters
and expression of tumor suppressor proteins (p53 and p16INK4a) and bcl-2 oncoprotein
Ζ. Mijovic, Μ. Kostov, D. Mihailovic, N. Ζivkovic, M. Stojanovic, M. Zdravkovic; pp 471-476 (Abstract, PDF)
Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction
Yan Guo, Wei Zhang, Yan-yan Yan, Cun-gen Ma, Xia Wang, Chen Wang, Jia-li Zhao; pp 477-485 (Abstract, PDF)
Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population
J. Ruiz-Cosano, D. Torres-Moreno, P. Conesa-Zamora; pp 486-490 (Abstract, PDF)
The Euphorbia lunulata Bge extract inhibits proliferation of human hepatoma HepG2 cells and induces
apoptosis
Feng Gao, Zhaoying Fu, Hongying Tian, Zhiying He; pp 491-495 (Abstract, PDF)
Cemented versus cementless endoprostheses for lower limb salvage surgery
E. Pala, A. F. Mavrogenis, A. Angelini, E. R. Henderson, G. Douglas Letson, P. Ruggieri; pp 496-503 (Abstract, PDF)
GE132+Natural: Novel promising dietetic supplement with antiproliferative influence on prostate,
colon, and breast cancer cells
I. Okic-Djordjevic, D. Trivanovic, J. Krstic, A. Jaukovic, S. Mojsilovic, J. F. Santibanez, M. Terzic, D. Vesovic,
D. Bugarski; pp 504-510 (Abstract, PDF)
Perception about influenza and pneumococcal vaccines and vaccination coverage among patients
with malignancies and their family members
Y. Urun, H. Akbulut, A. Demirkazik, F. Cay Senler, G. Utkan, H. Onur, F. Icli; pp 511-515 (Abstract, PDF)
Disclosure of cancer diagnosis: the Greek experience
S. Tsoussis, M. Papadogiorgaki, E. Markodimitraki, G. Delibaltadakis, A. Strevinas, M. Psyllakis, K. Tabakaki,
I. Drossitis, A. Kabourakis, E. Papadimitraki, S. Krypotos, K. Daskalakis, G. Fragiadaki, E. Zoumadaki,
S. Apostolakis; pp 516-526 (Abstract, PDF)
Informing cancer patient based on his type of personality: The avoidant patient
G. Kallergis; pp 527-531 (Abstract, PDF)
High-dose tamoxifen in breast cancer bone metastasis
G.P. Stathopoulos, D. Trafalis; pp 532-534 (Abstract, PDF)
Only particular cytogenetic events are related to disease progression in sequential cytogenetic studies
in myelodysplastic syndromes
D. Marisavljevic, M. Pantic, V. Djordjevic; pp 535-536 (Abstract, PDF)
The treatment of melanoma at Westminster Hospital in the 20th century
S. Retsas; pp 537-543 (Abstract, PDF)
Tyrosine kinase inhibitors may change the metastatic pattern
M.A. N. Sendur, S. Aksoy, N. Y. Ozdemir, N. Zengin; pp 544 (Abstract, PDF)
Vemurafenib-induced hypertension: is it real?
O. Balakan, T. Babacan, K. Altundag; pp 545 (Abstract, PDF)
A case of thoracic ancient schwannoma with a challenging approach
G. Dimitrakakis, K. Whitehouse, D. Challoumas, P. O’Keefe; pp 545-546 (Abstract, PDF)
Adult Langerhans’ cell histiocytosis: a rare cause of parotid gland enlargement
T. Babacan, I. H. Turkbeyler, O. Zengin, A. Gokhan, F. Sarici, K. Altundag; pp 546-547 (Abstract, PDF)
Etoposide hypersensitivity
O.Yersal, S.Barutca, N.Meydan; pp 547-548 (Abstract, PDF)
Fertility sparing surgery for early cervical cancer
C. Iavazzo, K. Madhuri, N. Akrivos, A. Tailor, S. Butler-Manuel; pp 548-549 (Abstract, PDF)
Granulocyte colony stimulating factor-induced tumor lysis-like syndrome: leucolysis
T. Babacan, F. Sarici, A. Gokhan, O. Balakan, O. Keskin, K. Altundag; pp 549-550 (Abstract, PDF)
The distinguished surgeon Bertrand Bécane (1728-1802?) and the syphilitic theory of cancer
M. Karamanou, G. Tsoucalas, K. Laïos, C. Trompoukis, G. Androutsos; pp 551-553 (Abstract, PDF)
